Prognostic Value of Tpeak-Tend Interval in Early Diagnosis of Duchenne Muscular Dystrophy Cardiomyopathy
- PMID: 37510124
- PMCID: PMC10377932
- DOI: 10.3390/diagnostics13142381
Prognostic Value of Tpeak-Tend Interval in Early Diagnosis of Duchenne Muscular Dystrophy Cardiomyopathy
Abstract
The most common cause of death in patients with Duchenne muscular dystrophy (DMD) is cardiomyopathy. Our aim was to investigate the relationship between the Tpeak-Tend (Tp-e) interval and the premature ventricular contraction (PVC) burden and therefore early arrhythmic risk and cardiac involvement in DMD patients. Twenty-five patients with DMD followed by pediatric cardiology were included in the study. Those with a frequency of <1% PVC in the 24 h Holter were assigned to Group 1 (n = 15), and those with >1% were assigned to Group 2 (n = 10). Comparisons were made with healthy controls (n = 27). Left ventricular ejection fraction (LVEF) was lowest in Group 2 and highest in the control group (p < 0.001). LV end-diastolic diameter was greater in Group 2 than in Group 1 and the control group (p = 0.005). Pro-BNP and troponin levels were higher in Group 1 and Group 2 than in the control group (p = 0.001 and p < 0.001, respectively). Tp-e interval was longer in Group 2 compared to Group 1 and the control group (p < 0.001). The LVEF (OR 0.879, 95% CI 0.812-0.953; p = 0.002) and Tp-e interval (OR 1.181, 95% CI 1.047-1.332; p = 0.007) were independent predictors of PVC/24 h frequency of >1%. A Tp-e interval > 71.65 ms predicts PVC > 1%, with a sensitivity of 80% and a specificity of 90% (AUC = 0.842, 95% CI (0.663-1.000), p = 0.001). Determination of Tp-e prolongation from ECG data may help in the determination of cardiac involvement and early diagnosis of arrhythmic risk in DMD.
Keywords: Duchenne muscular dystrophy; Tpeak–Tend interval; premature ventricular contraction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- McNally E.M., Kaltman J.R., Benson D.W., Canter C.E., Cripe L.H., Duan D., Finder J.D., Groh W.J., Hoffman E.P., Judge D.P., et al. Working Group of the National Heart, Lung, and Blood Institute; Parent Project Muscular Dystrophy. Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation. 2015;131:1590–1598. doi: 10.1161/CIRCULATIONAHA.114.015151. - DOI - PMC - PubMed
-
- Romitti P.A., Zhu Y., Puzhankara S., James K.A., Nabukera S.K., Zamba G.K., Ciafaloni E., Cunniff C., Druschel C.M., Mathews K.D., et al. MD STARnet. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics. 2015;135:513–521. doi: 10.1542/peds.2014-2044. - DOI - PMC - PubMed
-
- Yiu E.M., Kornberg A.J. Duchenne muscular dystrophy. J. Paediatr. Child. Health. 2015;51:759–764. - PubMed
-
- Earl C.C., Pyle V.I., Clark S.Q., Annamalai K., Torres P.A., Quintero A., Damen F.W., Hor K.N., Markham L.W., Soslow J.H., et al. Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 2023;25:14. - PMC - PubMed
LinkOut - more resources
Full Text Sources